Key Events This Week
21 Sep: Stock opens week at Rs.381.55, gaining 2.26%
22 Sep: New 52-week high of Rs.408 and all-time high reached
24 Sep: Hits new 52-week high at Rs.419.05 and all-time high at Rs.418.1
25 Sep: Week closes at Rs.404.55, up 0.86% on the day
21 September 2026: Positive Start to the Week
Ind-Swift Laboratories Ltd began the week on a strong footing, closing at Rs.381.55, up Rs.8.45 or 2.26% from the previous Friday’s close of Rs.373.10. This gain outpaced the Sensex’s 0.46% rise to 35,787.64, signalling early bullish momentum. The stock traded on moderate volume of 39,791 shares, reflecting steady investor interest ahead of the week’s key developments.
22 September 2026: New 52-Week and All-Time Highs Amid Strong Momentum
On 22 September, Ind-Swift Laboratories Ltd surged to a new 52-week high of Rs.408 intraday, closing at Rs.405.90, a gain of Rs.24.35 or 6.38% on the day. Despite opening with a gap down of 2.14%, the stock rebounded strongly, demonstrating resilience and robust buying interest. This rally outperformed the Sensex, which declined 0.32% to 35,672.04, and the Pharmaceuticals & Biotechnology sector by over 6%. The stock’s volume spiked to 223,388 shares, indicating heightened investor participation.
Additionally, the stock reached an all-time high intraday of Rs.400 and closed at Rs.404.35, marking a 5.98% gain on the day. This milestone was supported by the stock trading above all key moving averages, signalling sustained bullish momentum. Delivery volumes increased significantly, with a 70.8% rise compared to the 5-day average, underscoring strong accumulation.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
23 September 2026: Minor Pullback Amid Market Gains
The stock experienced a slight decline on 23 September, closing at Rs.405.05, down Rs.0.85 or 0.21% from the previous day’s close. This minor pullback occurred despite the Sensex rising 0.56% to 35,870.78, reflecting a cautious market environment. Volume moderated to 61,467 shares, and delivery volumes remained elevated at 3.47 lakh shares, representing 39.89% of total volume, above the trailing one-month average.
24 September 2026: New 52-Week and All-Time Highs Amid Market Weakness
Ind-Swift Laboratories Ltd reached a new 52-week high of Rs.419.05 intraday on 24 September, closing at Rs.401.10, down Rs.3.95 or 0.98% on the day. The stock also hit an all-time high of Rs.418.1 intraday, closing with a 2.15% gain relative to the previous close of Rs.392.90 (adjusted). This performance was notable given the Sensex’s sharp decline of 1.62% to 35,291.38, reflecting the stock’s resilience amid a bearish broader market.
The stock outperformed its sector by 0.51% and maintained its position above all major moving averages, reinforcing the bullish technical outlook. The Mojo Score remained steady at 56.0 with a Hold grade, upgraded from Sell earlier in the year. Despite the strong price action, the Relative Strength Index (RSI) indicated some caution due to potential overbought conditions.
25 September 2026: Week Closes on a Positive Note
On the final trading day of the week, Ind-Swift Laboratories Ltd closed at Rs.404.55, up Rs.3.45 or 0.86%, recovering from the previous day’s dip. The Sensex also rebounded modestly by 0.18% to 35,353.29. Volume was relatively low at 20,287 shares, suggesting consolidation after the week’s strong gains. The stock’s weekly performance of +8.43% contrasted sharply with the Sensex’s -0.76%, highlighting significant outperformance.
Ind-Swift Laboratories Ltd or something better? Our SwitchER feature analyzes this micro-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Daily Price Comparison: Ind-Swift Laboratories Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-21 | Rs.381.55 | +2.26% | 35,787.64 | +0.46% |
| 2026-09-22 | Rs.405.90 | +6.38% | 35,672.04 | -0.32% |
| 2026-09-23 | Rs.405.05 | -0.21% | 35,870.78 | +0.56% |
| 2026-09-24 | Rs.401.10 | -0.98% | 35,291.38 | -1.62% |
| 2026-09-25 | Rs.404.55 | +0.86% | 35,353.29 | +0.18% |
Key Takeaways
Ind-Swift Laboratories Ltd demonstrated remarkable resilience and strength throughout the week, achieving multiple new 52-week and all-time highs despite a broadly weak market. The stock’s 8.43% weekly gain starkly contrasts with the Sensex’s 0.76% decline, underscoring its outperformance and relative strength within the Pharmaceuticals & Biotechnology sector.
Strong technical indicators, including trading above all major moving averages and bullish MACD and Bollinger Bands, support the ongoing upward momentum. However, the bearish RSI on weekly and monthly charts suggests some caution for potential short-term consolidation.
Financially, the company reported robust short-term growth with a 221.27% increase in profit after tax for the nine months ended, and a 694.56% surge in quarterly profit before tax excluding other income. Despite below-average quality grades on long-term metrics, the company’s net cash position and zero promoter pledging provide a solid financial foundation.
Elevated delivery volumes and increased investor participation further reinforce the stock’s strong market interest. The Mojo Score of 56.0 and Hold rating reflect improved fundamentals and technical strength, upgraded from Sell earlier in the year.
Conclusion
Ind-Swift Laboratories Ltd’s performance in the week ending 25 September 2026 highlights a compelling growth trajectory marked by significant price appreciation, technical strength, and improving financial results. The stock’s ability to outperform the Sensex amid a challenging market environment and its sustained momentum within the Pharmaceuticals & Biotechnology sector underscore its evolving market position.
While some caution is warranted due to overbought technical signals and below-average quality metrics, the company’s strong short-term earnings growth and net cash status provide a supportive backdrop for its current valuation. Market participants will likely continue to monitor the stock’s price action closely as it navigates elevated levels and broader market volatility.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
